Nicole van der Weerden

Nicole van der Weerden is a seasoned professional in the biotechnology sector, currently serving as the Chief Operating Officer at Arovella Therapeutics since January 2023. With a long-standing tenure at Hexima Limited, Nicole has held various roles including CEO, Chief Operating Officer, and Non-Executive Director, contributing significantly to the identification and characterization of novel antifungal peptides through advanced screening and assay techniques. Previously, Nicole was a Research Fellow at La Trobe University and holds a Doctor of Philosophy in Biochemistry, a Bachelor of Science in Medical Science, and an MBA from Melbourne Business School.